Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00178399
Status:
COMPLETED
Last Update Posted:
2018-10-11
First Post:
2005-09-12
Brief Title:
A Study For Using Radiosurgery On Limited Metastases
Sponsor:
University of Rochester
Organization:
University of Rochester
Study Overview
Official Title:
A Pilot Study For Using Radiosurgery On Limited Metastases
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The standard therapy in cases such as yours is surgery radiation therapy chemotherapy or hormonal therapy alone or in combination The main purpose of this study is to evaluate whether radiosurgery alone affects your quality and length of life A second purpose of this study is to determine if the levels of special types of protein called cytokines found in the blood are related to your quality of life during your course of treatment and follow-up
Detailed Description:
In this research study high dose stereotactic body radiation therapy will be directed at the site of metastasis This treatment will be given once a day 5 times a week Monday through Friday for one to four weeks depending on the location and size of the disease to be treated Blood for the cytokine tests will be drawn before your therapy starts weekly during therapy and at the follow-up visits as stated in the next paragraphs Two to four tablespoons of blood will be removed each time
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None